Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Assess the safety and toleration of CP-464,005 and Inhaler following 1-year (52 week)
administration to Type 1 and Type 2 diabetes patients (non-smokers)